‌

US Patent 8124773 1,8-naphthyridine compounds for the treatment of cancer

Patent 8124773 was granted and assigned to Sunesis Pharmaceuticals Inc on February, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

Sunesis Pharmaceuticals Inc

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Marc J. Evanchik0

Daniel C. Adelman0

Jeffrey A. Silverman0

Jeffrey William Jacobs0

Anantha Sudhakar0

Date of Patent

February 28, 2012

0

Patent Application Number

123047500

Date Filed

June 12, 2007

0

Patent Primary Examiner

0

Patent abstract

Compounds and compositions for treating, preventing or managing cancer are disclosed. The compositions provided herein comprise SNS-595 and N-desmethyl-SNS-595. Also provided are pharmaceutical compositions comprising the compounds and methods of treatment using the compounds and compositions.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8124773 1,8-naphthyridine compounds for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.